Attachment 27 7 Day Emergency Federal Register Notice

10494

Federal Register / Vol. 80, No. 38 / Thursday, February 26, 2015 / Notices

Monday through Friday, and will be
posted to the docket at http://
www.regulations.gov.
Transcripts: As soon as a transcript is
available, FDA will post it at http://
wwww.fda.gov/NewsEvents/
MeetingsConferencesWorkshops/
ucm433552.htm.
Dated: February 20, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015–03974 Filed 2–25–15; 8:45 am]
BILLING CODE 4164–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration

rmajette on DSK2VPTVN1PROD with NOTICES

Advisory Committee on Organ
Transplantation; Notice of Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
Name: Advisory Committee on Organ
Transplantation (ACOT).
Date and Time: March 12, from 8:30
a.m. to 4:30 p.m. Eastern Standard
Time. March 13, from 8:30 a.m. to 12:30
p.m. Eastern Standard Time.
Place: Health Resources and Services
Administration, 5600 Fishers Lane,
Room 05W11, Rockville, MD 20857.
Status: The meeting will be open to
the public.
Purpose: Under the authority of 42
U.S.C. Section 217a, Section 222 of the
Public Health Service Act, as amended,
and 42 CFR 121.12 (2000), ACOT was
established to assist the Secretary in
enhancing organ donation, ensuring that
the system of organ transplantation is
grounded in the best available medical
science, and assuring the public that the
system is as effective and equitable as
possible, thereby increasing public
confidence in the integrity and
effectiveness of the transplantation
system. ACOT is composed of up to 25
members including the Chair. Members
serve as Special Government Employees
and have diverse backgrounds in fields
such as organ donation, health care
public policy, transplantation medicine
and surgery, critical care medicine, and
other medical specialties involved in
the identification and referral of donors,
non-physician transplant professions,
nursing, epidemiology, immunology,
law and bioethics, behavioral sciences,
economics and statistics, as well as
representatives of transplant candidates,
transplant recipients, organ donors, and
family members.

VerDate Sep<11>2014

15:27 Feb 25, 2015

Jkt 235001

Agenda: The Committee will hear
presentations, including those on the
following topics: Kidney Paired
Donation; Vascularized Composite
Allografts; Donor Management
Research; Living Donation; and the
Affordable Care Act and
Transplantation. Agenda items are
subject to change as priorities indicate.
After Committee discussions,
members of the public will have an
opportunity to comment. Because of the
Committee’s full agenda and timeframe
in which to cover the agenda topics,
public comment will be limited. All
public comments will be included in
the record of the ACOT meeting.
Meeting summary notes will be posted
on the Department’s organ donation
Web site at http://www.organdonor.gov/
legislation/advisory.html#meetings.
The draft meeting agenda will be
posted on www.blsmeetings.net/ACOT.
Those participating on this meeting
should pre-register by visiting
www.blsmeetings.net/ACOT. The
deadline to pre-register for this meeting
is Wednesday, March 11, 2015.
Registration will be confirmed on site.
For all logistical questions and
concerns, please contact Anita Allen,
Seamon Corporation at 301–658–3442
or send an email to aallen@
seamoncorporation.com.
Public Comment: It is preferred that
persons interested in providing an oral
presentation email a written request,
along with a copy of their presentation,
to Patricia Stroup, MBA, MPA,
Executive Secretary, Healthcare Systems
Bureau, Health Resources and Services
Administration, at [email protected].
Requests should contain the name,
address, telephone number, email
address, and any business or
professional affiliation of the person
desiring to make an oral presentation.
Groups having similar interests are
requested to combine their comments
and present them through a single
representative.
The allocation of time may be
adjusted to accommodate the level of
expressed interest. Persons who do not
file an advance request for a
presentation, but desire to make an oral
statement, may request it during the
public comment period. Public
participation and ability to comment
will be limited to time as it permits. FOR
FURTHER INFORMATION CONTACT: Patricia
Stroup, MBA, MPA, Executive
Secretary, Healthcare Systems Bureau,
Health Resources and Services
Administration, 5600 Fishers Lane,

PO 00000

Frm 00040

Fmt 4703

Sfmt 4703

Room 17W65, Rockville, MD 20857;
telephone (301) 443–1127.
Jackie Painter,
Director, Division of the Executive Secretariat.
[FR Doc. 2015–03929 Filed 2–25–15; 8:45 am]
BILLING CODE 4165–15–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review;
Emergency Clearance Request Human
Influenza Surveillance of Health Care
Centers in the United States and
Taiwan
In accordance with Section
3507(j) of the Paperwork Reduction Act
of 1995, the National Institute of Allergy
and Infectious Diseases (NIAID), the
National Institutes of Health (NIH), has
submitted to the Office of Management
and Budget (OMB) a request for
emergency review and processing of this
information collection by March 7,
2015. NIAID is requesting emergency
processing of this information
collection, pursuant to 5 CFR 1320.13,
because NIAID cannot reasonably
comply with the normal clearance
procedures which would cause a delay
and likely prevent or substantially
disrupt the collection of information. A
delay in starting the information
collection would hinder the agency in
accomplishing its mission to the
detriment of the public good. Public
harm could result through the loss of
critically needed information to
understand the causes of severity of
influenza and associated morbidity and
mortality during the Northern
hemisphere 2014–15 influenza season.
The National Institutes of Health may
not conduct or sponsor, and the
respondent is not required to respond
to, an information collection that has
been extended, revised, or implemented
on or after October 1, 1995, unless it
displays a currently valid OMB control
number. Written comments and/or
suggestions from the public and affected
agencies are invited on one or more of
the following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the

SUMMARY:

E:\FR\FM\26FEN1.SGM

26FEN1

Federal Register / Vol. 80, No. 38 / Thursday, February 26, 2015 / Notices
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
DATES: Comment due date: Comments
regarding this information collection are
best assured of having their full effect if
received within 7 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and

10495

disease—a critical knowledge gap
impacting effectiveness of decisionmaking around patient care. The 2014–
15 influenza season is unique because
the dominant circulating strain is an
H3N2 strain that is not sensitive to the
immunity induced by the influenza
vaccine formulation administered to the
general public. Our study will provide
insight into viral determinants that may
be contributing to the severity of
influenza and associated morbidity and
mortality this season. Capturing samples
from this influenza season is essential
for understanding the public health
implications the virus may have in the
future, and discerning the reasons
behind the severity of the disease it
causes.
OMB approval is requested for 6
months. There are no costs to
respondents other than their time. The
total estimated annualized burden hours
are 500.

instruments, contact Dr. Diane Post,
Program Officer, Respiratory Diseases
Branch, NIAID, NIH 5601 Fishers Lane,
Bethesda, MD or call non-toll-free
number at 240–627–3348 or email your
request, including your address to:
[email protected]
SUPPLEMENTARY INFORMATION:
Proposed Collection: Human
Influenza Surveillance of Health Care
Centers in the United States and
Taiwan, (NIAID), 0925—NEW, National
Institute of Allergy and Infectious
Diseases (NIAID), National Institutes of
Health (NIH).
Need and Use of Information
Collection: This study will identify
individuals with influenza through
focused surveillance in key regions of
the United States and Taiwan, rapidly
identify circulating influenza strains to
identify those with pandemic potential
and create an invaluable bank of human
samples from patients with influenza to
characterize the basis of severe

ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent

Number of
respondents

Number of
responses per
respondent

Average
burden per
response
(in hours)

Total burden
hours

Patients ............................................................................................................

500

2

30/60

500

Dated: February 20, 2015.
Dione Washington,
Project Clearance Liaison, NIAID, NIH,
NIAID, NIH.
[FR Doc. 2015–04069 Filed 2–25–15; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health

rmajette on DSK2VPTVN1PROD with NOTICES

Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.

VerDate Sep<11>2014

15:27 Feb 25, 2015

Jkt 235001

Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Fellowships: Risk, Prevention, and Health
Behavior Overflow.
Date: March 18, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Lee S. Mann, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3224,
MSC 7808, Bethesda, MD 20892, 301–435–
0677, [email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Innate/
Adaptive Immunology and Vaccine
Development.
Date: March 19–20, 2015.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Patrick K. Lai, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2215,
MSC 7812, Bethesda, MD 20892, 301–435–
1052, [email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Fellowships: Risk, Prevention and Health
Behavior.

PO 00000

Frm 00041

Fmt 4703

Sfmt 9990

Date: March 23–24, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Martha M. Faraday, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3110,
MSC 7808, Bethesda, MD 20892, (301) 435–
3575, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 20, 2015.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–03936 Filed 2–25–15; 8:45 am]
BILLING CODE 4140–01–P

E:\FR\FM\26FEN1.SGM

26FEN1